Polymeric micelle drug-loaded composition for aerosol inhalation as well as preparation method and application of polymeric micelle drug-loaded composition

A technology of atomization inhalation and polymer glue, which is applied in the direction of drug combination, pharmaceutical formula, medical preparations of non-active ingredients, etc., can solve the problems of drug toxicity and side effects, and achieve the effect of high safety and improved stability

Active Publication Date: 2021-05-14
北京正隆医药研究院有限责任公司
View PDF5 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0011] In order to solve the problem in the prior art that voriconazole is easy to cause toxic and side effects to the drug when taken orally or injected, the object of the present invention is to provide a polymer micelle drug-loaded composition for atomized inhalation and its preparation method and application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Polymeric micelle drug-loaded composition for aerosol inhalation as well as preparation method and application of polymeric micelle drug-loaded composition
  • Polymeric micelle drug-loaded composition for aerosol inhalation as well as preparation method and application of polymeric micelle drug-loaded composition
  • Polymeric micelle drug-loaded composition for aerosol inhalation as well as preparation method and application of polymeric micelle drug-loaded composition

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0060] The preparation of embodiment 1 voriconazole micelles

[0061] (1) Weigh 250 mg of mPEG-PDLLA and 40 mg of voriconazole at a room temperature of 10-30° C., place them in a mixed solution of 20 ml of glycerin (or propylene glycol) and 10 ml of ethanol, and stir slowly to dissolve. Under the condition of a magnetic stirring rate of 720rpm, slowly drop this solution into 20ml of sterile water for injection (WFI) at a rate of 1sec., and continue to stir for 10min. The obtained nanoparticle solution was rotary evaporated at 30° C. to remove the solvent to obtain a VCZ / mPEG-PDLLA-drug thin film. Dissolve the above VCZ / mPEG-PDLLA with 8 mL of sterile water for injection preheated to 30°C, and collect the dissolved matrix-drug film solution. Add 350 mg of mannitol or 50 mg of trehalose and 50 mg of sucrose to the solution, and continue stirring until the solution becomes clear.

[0062] (2) Take the filter membrane with hydrophilic polyvinylidene fluoride (PVDF) with a pore siz...

Embodiment 2

[0064] Embodiment 2 polymer micelles are selected

[0065] Tests have proved that the used auxiliary material mPEG-PDLLA has a very narrow molecular weight distribution coefficient and high purity, and its gel permeation chromatogram is shown in the attached figure 2 .

Embodiment 3

[0067] (1) Weigh 200 mg of mPEG-PDLLA and 10 mg of voriconazole at a room temperature of 10-30° C., place them in a mixed solution of 20 ml of glycerin (or propylene glycol) and 10 ml of ethanol, and stir slowly to dissolve. Under the condition of a magnetic stirring rate of 720rpm, slowly drop this solution into 20ml of sterile water for injection (WFI) at a rate of 1sec., and continue to stir for 10min. The obtained nanoparticle solution was rotary evaporated at 30° C. to remove the solvent to obtain a VCZ / mPEG-PDLLA-drug thin film. Dissolve the above VCZ / mPEG-PDLLA with 8 mL of sterile water for injection preheated to 30°C, and collect the dissolved matrix-drug film solution. Add 50 mg of sucrose to this solution, and continue stirring until the solution becomes clear.

[0068] (2) Take the filter membrane with hydrophilic polyvinylidene fluoride (PVDF) with a pore size of 0.2 μm, put it on the filter cartridge of the filter, assemble the filter, and put the assembled filt...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
Apertureaaaaaaaaaa
Login to View More

Abstract

The embodiment of the invention relates to a polymeric micelle drug-loaded composition for aerosol inhalation as well as a preparation method and application thereof, and belongs to the field of new drug delivery systems, the composition comprises a water-soluble nano-micelle formed by an amphiphilic block copolymer loaded antifungal therapeutic drug, and pharmaceutically acceptable pharmaceutic adjuvants, the amphiphilic block copolymer contains a hydrophilic chain segment and a hydrophobic chain segment, and the antifungal therapeutic drug is an imidazole or triazole antifungal therapeutic drug which is insoluble in water. According to the invention, a triazole antifungal therapeutic drug (especially voriconazole) which is insoluble in water is prepared into a redissolved micelle solution, so that the stability of the drug in vitro is improved, and a novel pulmonary drug delivery preparation is prepared, so that the drugs such as voriconazole and the like achieve higher bioavailability and play a better therapeutic role in resisting pulmonary fungal infection.

Description

technical field [0001] The invention relates to the field of new drug delivery systems, in particular to a drug-loaded polymer micelle composition for nebulized inhalation, a preparation method and application thereof. Background technique [0002] According to WHO statistics, there are more than 270 species of fungi that can cause human diseases. Clinically, pulmonary fungal disease is common and difficult to diagnose, and difficult to grasp the timing of treatment. There are few types of antifungal drugs, poor curative effect, large side effects, and high price. Pulmonary mycosis has become a serious problem in clinical infection, and invasive aspergillosis can be as high as 50-100%. 86% of those who were not diagnosed and treated in time due to cryptococcosis died within one year, and 92% died within two years. Aspergillus infection almost all invades the human body from the respiratory tract, with pulmonary aspergillosis as the clinical manifestation (accounting for 8...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): A61K9/72A61K9/107A61K9/19A61K45/00A61K47/34A61K31/506A61P11/00A61P31/10
CPCA61K9/0078A61K9/1075A61K45/00A61K47/34A61K9/19A61P31/10A61P11/00A61K31/506Y02A50/30
Inventor惠建梅程梦威
Owner北京正隆医药研究院有限责任公司